Re-Purposing of FDA Approve Drugs for Tuberculosis Treatment

Notification

Announcement!

ISJEM Invites papers for various areas like engineering, Management, Science & other multi discplinary subjects. Please submit your paper for review.

ISJEM assigns a digital object identifier (DOI) to each published paper, making it easier for the paper to be cited in various major databases like Google Scholar, ResearchGate, Academia.edu, etc…

ISJEM takes 24–48 hours to publish a research paper. Within 24 hours, the submitted paper will be reviewed and notified of its status, and it will be published once the processing fee is successfully received.

Re-Purposing of FDA Approve Drugs for Tuberculosis Treatment

Version
Download 8
File Size 124.33 KB
File Count 1
Create Date 13 June 2023
Last Updated 13 June 2023

Re-Purposing of FDA Approve Drugs for Tuberculosis Treatment

Ag Maria Serena

B.sc Clinical Research & Healthcare Management

Sam Global University , Bhopal ( M.P.)

Tuberculosis is one of the most prevalent infections of human beings and it contributes considerably to illness and even death around the Global . It spread by inhaling tiny droplets of saliva from the cough or sneezes of an infected person .

It affects long parenchyma which is caused by Mycobacterium Tuberculosis currently , India is the highest Tb burden country in the world , Home to 20% off cases occurring globally because of TB, maximum people are dying every year approximately 0.37 million in India itself.

Download